Holen Sie sich die Stockscreener-App
0.3241
4.89%
0.0151
Handel nachbörslich:
.32
-0.0041
-1.27%
Finanzdaten der Ernexa Therapeutics Inc-Aktie (ERNA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | 0.001 | 0.487 | -0.048 |
| Operating Expenses |
27.00%
1.993
|
2.73 | 2.698 | 2.806 | 4.883 |
| Depreciation and Amortization |
0.00%
0.10
|
0.10 | - | - | - |
| Operating Income/Loss |
27.00%
-1.993
|
-2.73 | -2.697 | -2.259 | -4.931 |
| Nonoperating Income/Loss |
113.89%
0.759
|
-5.464 | -3.051 | -24.33 | -0.595 |
| Income/Loss From Continuing Operations Before Tax |
84.94%
-1.234
|
-8.194 | -5.748 | -26.59 | -5.526 |
| Income Tax Expense/Benefit |
25.00%
0.006
|
0.008 | 0.011 | 0.012 | 0.003 |
| Income/Loss From Continuing Operations After Tax |
84.88%
-1.24
|
-8.202 | -5.759 | -26.60 | -5.529 |
Net Income/Loss
|
84.88%
-1.24
|
-8.202 | -5.759 | -26.60 | -5.529 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | 0.008 | - | 0.008 |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
84.58%
8.226
|
53.36 | 8.237 | 5.41 | 5.41 |
| Diluted Average Shares |
84.58%
8.226
|
53.36 | 8.237 | 5.41 | 5.41 |
| Basic Earnings Per Share |
0.00%
-0.15
|
-0.15 | 3.91 | -4.92 | -1.02 |
| Diluted Earnings Per Share |
0.00%
-0.15
|
-0.15 | 3.91 | -4.92 | -1.02 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | 0.008 | - | 0.008 |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):